All news

Morgan Stanley lifts IRON target to

Alpha Vantage · TradingView · · AI-summarised by FinFlash

Morgan Stanley has maintained its "Overweight" rating for Disc Medicine and increased its price target from $92 to

Read original source

IRON company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.